AI empowers researchers to make significant breakthroughs in understanding disease mechanisms, discovering biomarkers, and developing personalized treatment approaches.
Ever since the emergence of COVID-19, it has caused the ripples of research in biomedical sciences, pathology, virology, genetics, pharmacology and drug designing.
Chronic and especially cardiometabolic diseases are the culmination of multiple risk factors ranging from genetic predispositions and sedentary lifestyles to stress.
